Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 12.9.2016 | EN | Official Journal of the European Union | C 335/51 |

---

Action brought on 28 July 2016 — Stada Arzneimittel v EUIPO — Vivatech (Immunostad)

(Case T-403/16)

(2016/C 335/68)

Language in which the application was lodged: German

Parties

Applicant: Stada Arzneimittel AG (Bad Vilbel, Germany) (represented by: R. Kaase and J. Plate, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Vivatech (Paris, France)

Details of the procedure before EUIPO

Proprietor of the mark at issue: the applicant

Mark at issue: EU word mark ‘Immunostad’ — EU trade mark No 9 552 225

Proceedings before EUIPO: invalidity proceedings

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 19 April 2016 in Case R 863/2015–5

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | order EUIPO to bear the costs, including the costs of the appeal. |

Pleas in law

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation No 207/2009; |

|  |  |
| --- | --- |
| — | Infringement of Article 75 of Regulation No 207/2009. |

---

[Top](#document1)